-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$27.00115.48% Upside
Olema Pharmaceuticals, Inc. Frequently Asked Questions
-
What analysts cover Olema Pharmaceuticals, Inc.?
Olema Pharmaceuticals, Inc. has been rated by research analysts at H.C. Wainwright, Goldman Sachs in the past 90 days.